Skip to content

Clinical trials

Endocrine System Diseases trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine System Diseases Country / region: Spain Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20141
20151
20161
20174
20181
20191
20202
20213
20222
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting5
Active, not recruiting4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Ascendis Pharma Endocrinology Division A/S2
Pfizer2
AbbVie1
Alexion Pharmaceuticals, Inc.1
Ascendis Pharma A/S1
AstraZeneca1
Celgene1
Diamyd Medical AB1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine System Diseases23
Endocrine Gland Neoplasms8
Neoplasms8
Neoplasms by Site8
Glucose Metabolism Disorders7
Diabetes Mellitus6
Digestive System Neoplasms6
Metabolic Diseases6
Diabetes Mellitus, Type 25
Digestive System Diseases5

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.